Condition (MeSH)
Remission, Spontaneous
ClinicalTrials.gov lists 5 trials for Remission, Spontaneous or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
5 of the 5 trials are tagged with Remission, Spontaneous itself; the rest are tagged with a narrower condition beneath it.
When did Remission, Spontaneous trials start? (4)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Trials over time, by phase
- Phase 2
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2022 | 1 |
| 2014 | 1 |
| 2004 | 1 |
No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 5 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Remission, Spontaneous trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2 | 1 |
| Not applicable | 3 |
| Observational | 1 |
How many Remission, Spontaneous trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Active, not recruiting | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Remission, Spontaneous? (219)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Regression of high-grade squamous intraepithelial cervical lesions and associated risk factors (RECER). | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2025 | Yes |
| Predictors of Spontaneous Remission of Problematic Internet Use in Adolescence: A One-Year Follow-Up Study. | International journal of environmental research and public health | 2020 | Yes |
| Vasa previa: a multicenter retrospective cohort study. | American journal of obstetrics and gynecology | 2019 | Yes |
| Frequency of spontaneous resolution of vasa previa with advancing gestational age. | American journal of obstetrics and gynecology | 2019 | Yes |
| Functional remission in schizophrenia: A FROGS-based definition and its convergent validity. | Psychiatry research | 2018 | Yes |
Showing 5 of 219 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.